Genomma Lab InternacionalB de CV (MEX:LABB) EBIT per Share : MXN4.08 (TTM As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV EBIT per Share?

Genomma Lab InternacionalB de CV's EBIT per Share for the three months ended in Mar. 2025 was MXN0.95. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was MXN4.08.

During the past 12 months, the average EBIT per Share Growth Rate of Genomma Lab InternacionalB de CV was 19.50% per year. During the past 3 years, the average EBIT per Share Growth Rate was 10.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's EBIT per Share or its related term are showing as below:

MEX:LABB' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -58.9 Med: 8.5 Max: 126.2
Current: 10.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Genomma Lab InternacionalB de CV was 126.20% per year. The lowest was -58.90% per year. And the median was 8.50% per year.

MEX:LABB's 3-Year EBIT Growth Rate is ranked better than
53.37% of 832 companies
in the Drug Manufacturers industry
Industry Median: 8.7 vs MEX:LABB: 10.30

Genomma Lab InternacionalB de CV's EBIT for the three months ended in Mar. 2025 was MXN921 Mil.

Genomma Lab InternacionalB de CV EBIT per Share Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV EBIT per Share Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

2.60

2.65

2.78

2.66

3.86

Genomma Lab InternacionalB de CV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															0.82	1.11	1.16	0.87	0.95

Genomma Lab InternacionalB de CV EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Genomma Lab InternacionalB de CV's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	3778.891	/	978.430
=	3.86

Genomma Lab InternacionalB de CV's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	921.274	/	973.793
=	0.95

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN4.08

Genomma Lab InternacionalB de CV (MEX:LABB) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Genomma Lab InternacionalB de CV EBIT per Share Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

GNMLF:USA GEKA:Germany

Address

Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines